Results of RECORD Avandia study presented to the American Diabetes Association
The results of the RECORD study was presented at the American Diabetes Association meeting in New Orleans. It indicates that use of Avandia together with regular diabetes treatment to reduce blood glucose in type 2 Diabetes does not raise risk of cardiovascular disease or death. However, taking Avandia multiplies the risk of heart failure by more than 2 times and increases the risk of fracture mostly in women.
Click here to read the original article (forbes.com)
Relevant External Links:
Lawsuits of Interest
Elidel (Pimecrolimus)